tiprankstipranks
ResMed Inc Director Plans Sale of 2,000 Shares
Company Announcements

ResMed Inc Director Plans Sale of 2,000 Shares

Story Highlights

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

An announcement from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) is now available.

ResMed Inc has announced the proposed sale of 2,000 common shares by director Peter C. Farrell, valued at approximately $500,000. This transaction, conducted under Rule 144 of the Securities Act of 1933, is part of a series of sales over recent months, reflecting possible strategic financial management decisions by the director.

More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh

ResMed Inc is a company operating in the healthcare industry, specializing in the manufacturing and distribution of equipment related to sleep disorders, respiratory care, and other medical devices. The company focuses on providing innovative solutions for the management of sleep apnea and other chronic respiratory conditions.

YTD Price Performance: 5.96%

Average Trading Volume: 910,617

Technical Sentiment Consensus Rating: Sell

Current Market Cap: A$56.47B

For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App